Who is sponsoring NCT03474250?

NCT03474250 is sponsored by Sheba Medical Center.

What drugs are being tested in NCT03474250?

Interventions in NCT03474250: Magnetic Resonance test for kidney.

What condition does NCT03474250 study?

NCT03474250 studies Renal Infarction.

Is NCT03474250 still recruiting?

NCT03474250 is currently status unknown. Last updated 1 May 2018.

Last reviewed 2018-05-01 · How we verify

NCT03474250

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trans-aortic Valve Replacement and Renal Infarction

Status unknown Last updated 1 May 2018

What this trial tests

trial testing Magnetic Resonance test for kidney in Renal Infarction in 20 participants. Status unknown.

Timeline

1 April 2018

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	Sheba Medical Center
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	1 April 2018
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across Israel

Drugs / interventions tested

Magnetic Resonance test for kidney

Conditions studied

Renal Infarction — all drugs for Renal Infarction →

Sponsor

Sheba Medical Center

Who can join

Adults 18 to 99, any sex, with Renal Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Kidney Magnetic Resonance assessment before and after undergoing transcatheter aortic valve replacement

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sheba Medical Center trials

Trials by the same sponsor.

NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
NCT07523373 — Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch · NA · not yet recruiting
NCT07509229 — 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients · Phase 1, PHASE2 · not yet recruiting
NCT07405723 — Arm Position and Blood Pressure Measurement Accuracy During Pregnancy · NA · recruiting
NCT07474987 — Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03474250 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sheba Medical Center
Last refreshed: 1 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03474250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing